Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity
Open Access
- 1 October 2016
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (10) , 6023-6033
Abstract
Plasmodium falciparum , the deadliest species of malaria parasites, is dependent on glycolysis for the generation of ATP during the pathogenic red blood cell stage. Hexokinase (HK) catalyzes the first step in glycolysis, transferring the γ-phosphoryl group of ATP to glucose to yield glucose-6-phosphate. Here, we describe the validation of a high-throughput assay for screening small-molecule collections to identify inhibitors of the P. falciparum HK (PfHK). The assay, which employed an ADP-Glo reporter system in a 1,536-well-plate format, was robust with a signal-to-background ratio of 3.4 ± 1.2, a coefficient of variation of 6.8% ± 2.9%, and a Z′-factor of 0.75 ± 0.08. Using this assay, we screened 57,654 molecules from multiple small-molecule collections. Confirmed hits were resolved into four clusters on the basis of structural relatedness. Multiple singleton hits were also identified. The most potent inhibitors had 50% inhibitory concentrations as low as ∼1 μM, and several were found to have low-micromolar 50% effective concentrations against asexual intraerythrocytic-stage P. falciparum parasites. These molecules additionally demonstrated limited toxicity against a panel of mammalian cells. The identification of PfHK inhibitors with antiparasitic activity using this validated screening assay is encouraging, as it justifies additional HTS campaigns with more structurally amenable libraries for the identification of potential leads for future therapeutic development.Keywords
Funding Information
- HHS | National Institutes of Health (1R03HD081723)
- HHS | National Institutes of Health
This publication has 23 references indexed in Scilit:
- Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase2016
- Interrogating a Hexokinase-Selected Small-Molecule Library for Inhibitors of Plasmodium falciparum HexokinaseAntimicrobial Agents and Chemotherapy, 2013
- Identification of potent Yes1 kinase inhibitors using a library screening approachBioorganic & Medicinal Chemistry Letters, 2013
- Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate PotentialJournal of Medicinal Chemistry, 2011
- Branched tricarboxylic acid metabolism in Plasmodium falciparumNature, 2010
- Comparison of Bioluminescent Kinase Assays Using Substrate Depletion and Product FormationASSAY and Drug Development Technologies, 2009
- Compound Management for Quantitative High-Throughput ScreeningSLAS Technology, 2008
- RNAi-mediated replacement of morphine with the nonnarcotic alkaloid reticuline in opium poppyNature Biotechnology, 2004
- d-Lactate production in erythrocytes infected with Plasmodium falciparumMolecular and Biochemical Parasitology, 1990
- Glutathione stability and oxidative stress in P. falciparum infection in vitro: Responses of normal and G6PD deficient cellsBiochemical and Biophysical Research Communications, 1982